Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Portfolio Pulse from Avi Kapoor
Wall Street's most accurate analysts have spotlighted three high-dividend-yielding health care stocks: Pfizer Inc. (PFE), GSK plc (GSK), and CVS Health Corporation (CVS). Analysts have provided updated ratings and price targets for these stocks, and recent news events have been highlighted.
August 12, 2024 | 1:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
CVS Health Corporation (CVS) has received updated price targets from Deutsche Bank and Barclays, both maintaining a Hold or Equal-Weight rating. The company reported mixed Q2 earnings and cut annual profit guidance.
The mixed Q2 earnings and reduced annual profit guidance are likely to negatively impact CVS's stock price in the short term.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
GSK plc (GSK) has received a Buy rating from Jefferies and an upgrade from Guggenheim. The company reported strong Q2 sales, up 10% year-over-year.
The positive analyst ratings and strong Q2 sales performance are likely to positively impact GSK's stock price in the short term.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Pfizer Inc. (PFE) has received updated price targets from Barclays and Wells Fargo analysts, both maintaining an Equal-Weight rating. Recent news includes positive results from a Phase 3 trial for the Abrysvo vaccine.
The updated price targets and positive trial results are likely to boost investor confidence in Pfizer, potentially leading to a short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100